// App-Quantinova.ai

5030 : Tumor necrosis serves as a prognostic predictor in operable and stage I lung adenocarcinoma

Researchers

Presenter

  • Pei-Ying Lin

Principal Investigators

  • Tzu-Hung Hsiao

  • Pan-Chyr Yang

Medical Centers

  • Academia Sinica Taipei, Taipei, Taiwan

Locations

  • Taiwan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved